Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukemia in the central nervous system.

L Brinch1, S A Evensen, P Stavem

  • 1Section of Hematology, Rikshospitalet, Oslo, Norway.

Acta Medica Scandinavica
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2016
Same author

Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT.

Bone marrow transplantation·2012
Same author

Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients.

Journal of internal medicine·2012
Same author

Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation.

Bone marrow transplantation·2012
Same author

Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy.

Bone marrow transplantation·2011
Same author

Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium.

Leukemia·2011
Same journal

On hereditary, non-hemolytic bilirubinemia.

Acta medica Scandinavica·2010
Same journal

Infections with leukopenia treated with sulfa compounds.

Acta medica Scandinavica·2010
Same journal

A peculiar conduction disturbance, persisting latently after recovery from complete heart block and disclosed only by electrocardiography following exercise.

Acta medica Scandinavica·2010
Same journal

Titration with Weichbrodt's reagent of serum, particularly in the case of gall-liver diseases.

Acta medica Scandinavica·2010
Same journal

Arthralgia due to nervous causes.

Acta medica Scandinavica·2010
Same journal

Auricular standstill.

Acta medica Scandinavica·2010
See all related articles

Central nervous system (CNS) leukemia occurred in acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML) patients despite prophylaxis. Prompt diagnosis and treatment are crucial for managing CNS leukemia and may not shorten survival.

Area of Science:

  • Hematology
  • Oncology
  • Neurology

Background:

  • Central nervous system (CNS) leukemia is a serious complication of acute leukemia.
  • Understanding the risk factors and outcomes of CNS leukemia is vital for effective patient management.

Purpose of the Study:

  • To determine the frequency of CNS leukemia in adult patients with acute leukemia.
  • To analyze risk factors, treatment strategies, and survival outcomes for CNS leukemia.

Main Methods:

  • Retrospective analysis of adult acute leukemia patients (15-59 years) treated between 1971-1986.
  • Evaluation of CNS leukemia incidence, morphology, prophylaxis, treatment, and survival.

Main Results:

  • CNS leukemia developed in 11.7% of ALL patients and 4.6% of AML patients.

Related Experiment Videos

  • M4/M5 myeloid blast morphology was associated with increased CNS relapse risk in AML.
  • Median survival after CNS leukemia diagnosis was 8 months for ALL and 6 months for AML.

    • Conclusions:

    • CNS leukemia remains a significant concern in acute leukemia, particularly with certain morphologies.
    • Intrathecal methotrexate prophylaxis was partially effective in ALL but absent in AML.
    • Active diagnosis and treatment are essential and likely do not compromise survival in CNS leukemia.